Galecto, Inc. (DMRA) vs MannKind Corporation (MNKD)
- Galecto, Inc. DMRA 18.42 −1.71%
- MannKind Corporation MNKD 3.04 −4.70%
Galecto, Inc. and MannKind Corporation are both Biotechnology companies. Galecto, Inc. is the larger, with a market value of $1.2B against $1.0B — 1.1× the size. Galecto, Inc. has the higher net margin (0.00% vs −11.1%) and the lower return on invested capital (0.00% vs 2.36%). Across the 13 metrics below, MannKind Corporation leads on 9 and Galecto, Inc. on 4.
Valuation
Profitability
| Metric | DMRA | MNKD | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 75.39% | 65.16% |
| Operating margin | 0.00% | 2.34% | 0.00% |
| Net margin | 0.00% | (11.08%) | 0.00% |
| Free cash flow margin | 0.00% | (4.61%) | 0.00% |
| Return on equity | (26.26%) | 71.36% | (56.36%) |
| Return on assets | (18.64%) | (7.62%) | (48.04%) |
| Return on invested capital | 0.00% | 2.36% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack